Literature DB >> 1759134

Long-term effect of vagotomy on gastric mucosa and Helicobacter pylori in duodenal ulcer patients.

A Peetsalu1, H I Maaroos, P Sipponen, M Peetsalu.   

Abstract

The purpose of the study was to evaluate the long-term effects of vagotomy on the morphological status and Helicobacter pylori infestation of the gastric mucosa. Endoscopy with biopsies (2 from antrum and 2 from corpus) was performed in 317 patients on whom vagotomy had been performed on an average 8 years earlier. The success of the vagotomy was estimated by the endoscopic Congo Red technique in 270 cases. Non-operated 187 duodenal ulcer patients were examined endoscopically and bioptically in a similar way and used as a reference series. Helicobacter pylori (HP) was determined by Giemsa staining of biopsy specimens in both series. In non-operated dudoenal ulcer patients, gastritis and HP behaved as expected from the data in literature: antral gastritis was present in nearly all cases (96%), while the corpus mucosa was normal or the process was retarded at the stage of superficial gastritis (76%) and atrophic changes were virtually lacking (1%). On the basis of the Congo Red test the vagotomized patients were separated into two groups: successfully operated, i.e., complete vagotomy, and incomplete vagotomy groups. The results of the examinations were independent of the kind of vagotomy performed, but related significantly to its completeness. The incomplete and complete groups differed significantly. The prevalence of atrophic changes (29%) in the corpus was significantly higher and that of superficial gastritis (69%) lower in the complete than in the incomplete vagotomy group, in which the prevalences were 12% and 85%, respectively. Likewise the prevalence and density of HP was lower in the complete vagotomy group but the difference was not statistically significant.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1759134

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  7 in total

1.  Proton pump inhibitors and gastric neoplasia.

Authors:  E J Kuipers
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

2.  Deficiency of the complex I of the mitochondrial respiratory chain but improved adenylate control over succinate-dependent respiration are human gastric cancer-specific phenomena.

Authors:  Marju Puurand; Nadežda Peet; Andres Piirsoo; Margot Peetsalu; Jaan Soplepmann; Meeli Sirotkina; Ants Peetsalu; Akseli Hemminki; Enn Seppet
Journal:  Mol Cell Biochem       Date:  2012-07-21       Impact factor: 3.396

3.  Duodenal ulcer promoting gene of Helicobacter pylori.

Authors:  Hong Lu; Ping-I Hsu; David Y Graham; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

4.  Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells.

Authors:  Marju Gruno; Nadezhda Peet; Andres Tein; Riina Salupere; Meeli Sirotkina; Julio Valle; Ants Peetsalu; Enn K Seppet
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

Review 5.  Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review.

Authors:  Richard H Turnage; George Sarosi; Byron Cryer; Stuart Spechler; Walter Peterson; Mark Feldman
Journal:  J Gastrointest Surg       Date:  2003 Jul-Aug       Impact factor: 3.452

6.  Helicobacter pylori-induced damage to the gastric mucosa is not modulated by previous vagotomy or medical treatment of peptic ulcer disease: a comparative study of vagotomized patients, medically treated peptic ulcer patients and community control subjects.

Authors:  Rolv-Ole Lindsetmo; Tor Jac Eide; Roar Johnsen; Arthur Revhaug
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

Review 7.  Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.

Authors:  E J Kuipers; E C Klinkenberg-Knol; S G Meuwissen
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.